These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1590103)

  • 1. Long-term evaluation of the clinical performance of the TCu200B and the TCu380A in Campinas, Brazil.
    Díaz J; Pinto Neto A; Díaz M; Marchi NM; Bahamondes L
    Adv Contracept; 1992 Mar; 8(1):67-72. PubMed ID: 1590103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the performances of TCu380A and TCu380S IUDs up to five years.
    Bahamondes L; Díaz J; Petta C; Monteiro I; Monteiro CD; Regina CH
    Adv Contracept; 1999; 15(4):275-81. PubMed ID: 11145369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the performance of the copper T380A IUD up to ten years. Is this IUD a reversible but potentially permanent method?
    Díaz J; Bahamondes L; Díaz M; Marchi N; Faúndes A; Marini M
    Adv Contracept; 1992 Dec; 8(4):275-80. PubMed ID: 1290329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.
    Contraception; 1997 Dec; 56(6):341-52. PubMed ID: 9494767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper-containing, framed intrauterine devices for contraception: a systematic review of randomized controlled trials.
    O'Brien PA; Kulier R; Helmerhorst FM; Usher-Patel M; d'Arcangues C
    Contraception; 2008 May; 77(5):318-27. PubMed ID: 18402846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women.
    Wu S; Hu J; Wildemeersch D
    Contraception; 2000 Feb; 61(2):91-8. PubMed ID: 10802273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries.
    Farr G; Amatya R
    Adv Contracept; 1994 Jun; 10(2):137-49. PubMed ID: 7942261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the TCu380A and Cu-Fix IUDs in an international randomized trail.
    Rosenberg MJ; Foldesy R; Mishell DR; Speroff L; Waugh MS; Burkman R
    Contraception; 1996 Apr; 53(4):197-203. PubMed ID: 8706436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of intrauterine devices: TCu380A and Flexigard].
    Andrade AT; Araujo DA; Abranches AA
    Bol Cent Biol Reprod; 1993; 12(1):16-9. PubMed ID: 12345520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial.
    Meirik O; Rowe PJ; Peregoudov A; Piaggio G; Petzold M;
    Contraception; 2009 Aug; 80(2):133-41. PubMed ID: 19631788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper containing, framed intra-uterine devices for contraception.
    Kulier R; Helmerhorst FM; O'Brien P; Usher-Patel M; d'Arcangues C
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005347. PubMed ID: 16856094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized multicentre trial of the Multiload 375 and TCu380A IUDs in parous women: three-year results. UNDP/UNFPA/WHO/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction: IUD Research Group.
    Contraception; 1994 Jun; 49(6):543-9. PubMed ID: 8070258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation rates and reasons for discontinuing TCu380A IUD use in Tabriz, Iran.
    Jenabi E; Alizade SM; Baga RI
    Contraception; 2006 Dec; 74(6):483-6. PubMed ID: 17157106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil.
    Díaz J; Faúndes A; Díaz M; Marchi N
    Contraception; 1993 Feb; 47(2):169-75. PubMed ID: 8449017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.